Utilizing Brazil´s New IP System for Pharma and Academics to Optimize Innovation
Explore how the IP landscape in Brazil is changing and how this affects academia and the pharmaceutical business in our webinar. Learn about fresh prospects for technology transfer, market access, and patent protection brought about by recent legislation. Universities, research facilities, and pharmaceutical businesses looking to increase their capacity for innovation in this fast-growing market should not miss this event.
Frequently Asked Questions About Innovation and IP in Brazil
-
How is Brazil's IP system changing for the pharmaceutical industry?
Brazil has reformed its patent examination processes, adopted international cooperation tools and introduced regulatory linkage, affecting drug approval and IP strategy for pharma companies.
-
What opportunities exist for pharma companies in Brazil's IP system?
Companies can leverage the Patent Prosecution Highway (PPH), accelerated examination tracks and biotech-specific provisions to reduce time to market.
-
How can academics commercialize IP in Brazil?
Brazil's Innovation Law enables technology transfer offices (NITs) at universities to license patents, create spin-offs and partner with private sector entities.
-
Who should watch this webinar?
Pharmaceutical companies, biotech researchers, university technology transfer offices and IP attorneys with interests in the Brazilian market.